You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nucleoside analogue

Showing 1 - 25 of 2,036
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Steatohepatitis in Chronic Hepatitis B

Completed
  • Fatty Liver
  • Chronic Hepatitis b
  • Antiviral Agents
  • Bangkoknoi, Bangkok, Thailand
    Faculty of Medicine Siriraj Hospital
Mar 30, 2022

Hepatitis B, Chronic Trial in Worldwide (Stop of therapy)

Active, not recruiting
  • Hepatitis B, Chronic
  • Stop of therapy
  • København, Denmark
  • +10 more
Sep 13, 2021

Stopping Antiviral Treatment in Chronic Hepatitis B

Recruiting
  • Chronic Hepatitis b
  • Hong Kong, Please Select One ..., Hong Kong
    Man Fung Yuen
Sep 28, 2021

Chronic Hepatitis b, Hepatitis B Reactivation Trial in Taiwan (Vemlidy)

Recruiting
  • Chronic Hepatitis b
  • Hepatitis B Reactivation
  • Chiayi City, Taiwan
  • +6 more
Aug 4, 2021

HIV Trial in United States (Lopinavir/Ritonavir, Abacavir sulfate, Nevirapine)

Completed
  • HIV Infections
  • Los Angeles, California
  • +22 more
Oct 28, 2021

HIV, Tuberculosis Trial in Bangkok (LPV/r)

Completed
  • HIV Infections
  • Tuberculosis
  • Bangkok, Thailand
    HIV-NAT Thai Red Cross AIDS Research Center
Jul 15, 2020

Chronic Hepatitis B Trial in Hong Kong (Treatment cessation)

Completed
  • Chronic Hepatitis B
  • Treatment cessation
  • Hong Kong, Hong Kong
    Department of Medicine, The University of Hong Kong, Queen Mary
Feb 6, 2020

Chronic Hepatitis B Trial in Singapore (stopping nucleos(t)ide therapy, Continue nucleos(t)ide analogue)

Unknown status
  • Chronic Hepatitis B
  • stopping nucleos(t)ide therapy
  • Continue nucleos(t)ide analogue
  • Singapore, Singapore
    National University Hospital
Sep 24, 2019

Treatment Optimization of Refractory

Recruiting
  • Hepatitis B, Chronic
  • Virus Diseases
  • original therapy
  • rescue therapy
  • Ankang, China
  • +12 more
Feb 1, 2023

Hepatitis B, HBV, Hepatitis B, Chronic Trial in Canada, United Kingdom (Inarigivir soproxil, Nucleoside/nucleotide (NUC)

Terminated
  • Hepatitis B
  • +2 more
  • Inarigivir soproxil
  • Nucleoside/nucleotide (NUC) analogue inhibitors
  • Calgary, Alberta, Canada
  • +6 more
Jul 20, 2020

Hepatitis B, Chronic Trial in Gothenburg (Stopping)

Not yet recruiting
  • Hepatitis B, Chronic
  • Stopping
  • Gothenburg, VGR, Sweden
    Infectious Diseases Clinic, Sahlgrenska University Hospital
Apr 13, 2022

Chronic Hepatitis B Virus Infection Trial in Kaohsiung, Taichung, Taipei (Ropeginterferon alfa-2b, Entecavir)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Kaohsiung, Taiwan
  • +4 more
Aug 12, 2022

HIV Trial in United States (Tenofovir, Abacavir)

Completed
Has Results
  • HIV Infections
  • Irvine, California
  • +4 more
Sep 23, 2021

HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated

Not yet recruiting
  • HBV
  • HCC
  • nucleoside analogues or interferon
  • Hefei, Anhui, China
  • +9 more
Jul 20, 2023

Sarcoma, Kaposi, HIV Trial in Puerto Rico, United States (Interferon alfa-2b, Didanosine)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Palo Alto, California
  • +12 more
Oct 28, 2021

Recurrent/Refractory Acute Myeloid Leukemia, MDS Trial in ChengDu (TQB2618 injection azacitidine, AZA decitabine, DAC)

Recruiting
  • Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
  • TQB2618 injection azacitidine, AZA decitabine, DAC
  • ChengDu, Sichuan, China
    West China Hospital of Sichuan University
Jun 16, 2022

Real-world Study Optimizing Nucleotide-analogues

Recruiting
  • Hepatitis B, Chronic
  • Hefei, Anhui, China
  • +43 more
Jul 7, 2023

Cirrhosis of Liver Due to Hepatitis B (Disorder) Trial in Guangzhou (pegylated interferon (Peg IFN)a-2b, Nucleoside

Recruiting
  • Cirrhosis of Liver Due to Hepatitis B (Disorder)
  • pegylated interferon (Peg IFN)α-2b
  • Nucleoside （acid）analogue (NAs)
  • Guangzhou, Guangdong, China
    Third Affliated Hospital of Sun Yat-sen University
Jun 19, 2019

Metastatic Colorectal Cancer Trial (CA102N, TAS-102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Sep 8, 2023

After Long-Term Antiviral Treatment for Chronic Hepatitis B

Completed
  • Chronic Hepatitis B e Antigen Positive
  • Chronic Hepatitis B e Antigen Negative
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Hepatitis B, Chronic Trial in Poland (DV-601, Entecavir)

    Completed
    • Hepatitis B, Chronic
    • Bydgoszcz, Poland
    • +3 more
    Apr 11, 2019

    Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

    Active, not recruiting
    • Leukemia
    • +7 more
    • Boston, Massachusetts
    • +10 more
    Jan 19, 2023

    HIV Trial in Puerto Rico, United States (Lamivudine, Stavudine, Zidovudine)

    Completed
    • HIV Infections
    • Birmingham, Alabama
    • +31 more
    Oct 27, 2021

    Cirrhosis, Liver, Portal Hypertension Trial in Beijing, Shanghai (Carvedilol)

    Recruiting
    • Cirrhosis, Liver
    • Portal Hypertension
    • Beijing, Beijing, China
    • +5 more
    Jan 26, 2022

    Hepatitis B, Chronic Trial in Guangzhou (pegylated interferon-alfa)

    Recruiting
    • Hepatitis B, Chronic
    • pegylated interferon-alfa
    • Guangzhou, Guangdong, China
      Department of Infectious Diseases, The Third Affliated Hospital
    Dec 20, 2021